NCT02675920View on ClinicalTrials.gov

A Study of HCC High Risk Group Using Two Surveillance Tools

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

November 28, 2014

Primary Completion Date

January 11, 2019

Study Completion Date

October 1, 2019

Conditions
HCC
Interventions
DRUG

non-ionic monomer iodinated CT contrast media

patients underwent contrast-enhanced CT using aforementioned CT contrast media (non-ionic monomer iodinated CT contrast media)

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Taejoon Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Reyon Pharmaceutical Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT02675920 - A Study of HCC High Risk Group Using Two Surveillance Tools | Biotech Hunter | Biotech Hunter